Case Report: Exceptional Response to Nivolumab Plus Ipilimumab in a Young Woman With TFE3-SFPQ Fusion Translocation-Associated Renal Cell Carcinoma.
Front Oncol
; 11: 793808, 2021.
Article
in En
| MEDLINE
| ID: mdl-34976834
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Front Oncol
Year:
2021
Document type:
Article
Affiliation country:
Estados Unidos